InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Engelbert Catherine M., Directeur. Director active across 2 companies, notably Royalty Pharma plc. Aggregated, 8 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €228k. Activity tracked since 25 June 2021. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Engelbert Catherine M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
4,545 shares0Class A Ordinary SharesSEC:0001796439-26-000003:0
7,614 shares0Class A Ordinary SharesSEC:0001802768-25-000061:0
9,293 shares0Class A Ordinary SharesSEC:0001802768-24-000029:0
38 shares@ US$281.034.3% of flowCommon StockSEC:0000063908-23-000078:0
Canonical exit: 2 Jul 2023 (T+90)
7,747 shares0Class A Ordinary SharesSEC:0001209191-23-039681:0
6,328 shares0Class A Ordinary SharesSEC:0000899243-22-024044:0
1,000 shares@ US$244.1895.7% of flowCommon StockSEC:0001567619-22-006022:0
Canonical exit: 29 May 2022 (T+90)
5,726 shares0Class A Ordinary SharesSEC:0000950103-21-009687:0
8 of 8 declarations
About Engelbert Catherine M.
Catherine M. Engelbert is a Director at Royalty Pharma plc and MCDONALDS CORP. She contributes to the strategic direction of these companies, bringing her experience to strengthen their market position.
